Publication:
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment

dc.contributor.coauthorSainz, Bruno, Jr.
dc.contributor.coauthorAlcala, Sonia
dc.contributor.coauthorGarcia, Elena
dc.contributor.coauthorSanchez-Ripoll, Yolanda
dc.contributor.coauthorAzevedo, Maria M.
dc.contributor.coauthorCioffi, Michele
dc.contributor.coauthorTatari, Marianthi
dc.contributor.coauthorMiranda-Lorenzo, Irene
dc.contributor.coauthorHidalgo, Manuel
dc.contributor.coauthorGomez-Lopez, Gonzalo
dc.contributor.coauthorCanamero, Marta
dc.contributor.coauthorKleeff, Joerg
dc.contributor.coauthorGarcia-Silva, Susana
dc.contributor.coauthorSancho, Patricia
dc.contributor.coauthorHermann, Patrick C.
dc.contributor.coauthorHeeschen, Christopher
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:20:03Z
dc.date.issued2015
dc.description.abstractObjectives The tumour stroma/microenvironment not only provides structural support for tumour development, but more importantly it provides cues to cancer stem cells (CSCs) that regulate their self-renewal and metastatic potential. This is certainly true for pancreatic ductal adenocarcinomas (PDAC), where tumour-associated fibroblasts, pancreatic stellate cells and immune cells create an abundant paracrine niche for CSCs via microenvironment-secreted factors. Thus understanding the role that tumour stroma cells play in PDAC development and CSC biology is of utmost importance. Design Microarray analyses, tumour microarray immunohistochemical assays, in vitro co-culture experiments, recombinant protein treatment approaches and in vivo intervention studies were performed to understand the role that the immunomodulatory cationic antimicrobial peptide 18/LL-37 (hCAP-18/LL-37) plays in PDAC biology. Results We found that hCAP-18/LL-37 was strongly expressed in the stroma of advanced primary and secondary PDAC tumours and is secreted by immune cells of the stroma (eg, tumour-associated macrophages) in response to tumour growth factor-beta 1 and particularly CSC-secreted Nodal/ActivinA. Treatment of pancreatic CSCs with recombinant LL-37 increased pluripotency-associated gene expression, self-renewal, invasion and tumourigenicity via formyl peptide receptor 2 (FPR2)- and P2X purinoceptor 7 receptor (P2X7R)-dependent mechanisms, which could be reversed by inhibiting these receptors. Importantly, in a genetically engineered mouse model of K-Ras-driven pancreatic tumourigenesis, we also showed that tumour formation was inhibited by either reconstituting these mice with bone marrow from cathelicidin-related antimicrobial peptide (ie, murine homologue of hCAP-18/LL-37) knockout mice or by pharmacologically inhibiting FPR2 and P2X7R. Conclusions Thus, hCAP-18/LL-37 represents a previously unrecognised PDAC microenvironment factor that plays a critical role in pancreatic CSC-mediated tumourigenesis.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipCH: ERC Advanced Investigator Grant (Pa-CSC 233460), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 256974 (EPC-TM-NET) and no 602783 (CAM-PaC), the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129 and PI12/02643) and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105
dc.description.sponsorshipboth Ministerio de Economia y Competitividad (es), Spain). BSJr: Ramon y Cajal Merit Award from the Ministerio de Economia y Competitividad, Spain and Clinic and Laboratory Integration Program (CLIP) grant from the Cancer Research Institute, NY, NY. MCi: La Caixa Predoctoral Fellowship.
dc.description.volume64
dc.identifier.doi10.1136/gutjnl-2014-308935
dc.identifier.eissn1468-3288
dc.identifier.issn0017-5749
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-84954363411
dc.identifier.urihttps://doi.org/10.1136/gutjnl-2014-308935
dc.identifier.urihttps://hdl.handle.net/20.500.14288/10654
dc.identifier.wos364863300013
dc.keywordsTumor-associated macrophages
dc.keywordsAntimicrobial protein hCAP-18/LL-37
dc.keywordsVitamin-D-Receptor
dc.keywordsPeptide LL-37
dc.keywordsCathelicidin LL-37
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofGut
dc.subjectGastroenterology and hepatology
dc.titleMicroenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorErkan, Murat Mert
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files